Eamon M. Berge
34 works · 1,343 citations · h-index 9
Top works
- Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer
- Identifying and Targeting ROS1 Gene Fusions in Non–Small Cell Lung Cancer
- A Brief Report of the Status of Central Nervous System Metastasis Enrollment Criteria for Advanced Non–Small Cell Lung Cancer Clinical Trials: A Review of the ClinicalTrials.gov Trial Registry
- Targeted Therapies in Non-Small Cell Lung Cancer: Emerging Oncogene Targets Following the Success of Epidermal Growth Factor Receptor
- A Phase II, Open-Label Study of Ramucirumab in Combination with Paclitaxel and Carboplatin as First-Line Therapy in Patients with Stage IIIB/IV Non–Small-Cell Lung Cancer
- Clinical Benefit From Pemetrexed Before and After Crizotinib Exposure and From Crizotinib Before and After Pemetrexed Exposure in Patients With Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer
- Analysis of resistance mechanisms to ALK kinase inhibitors in ALK+ NSCLC patients.
- Tivozanib: Practical implications for renal cell carcinoma and other solid tumors
- RET rearrangements detected by FISH in “pan-negative” lung adenocarcinoma.
- EGFR Exon 19 Deletion Mutations and Systemic/Central Nervous System Miliary Metastasis: Clinical Correlations and Response to Therapy
- Erlotinib Response in an NSCLC Patient with a Novel Compound G719D+L861R Mutation in EGFR
- Abstract LB-449: KRAS mutation and amplification status predicts sensitivity to antifolate therapies in non-small-cell lung cancer
- Re-examination of Maintenance Therapy in Non-Small Cell Lung Cancer with the Advent of New Anti-cancer Agents
- Development of Novel Targeted Agents in the Treatment of Metastatic Colorectal Cancer
- Clinical benefit from pemetrexed before and after crizotinib exposure in patients with ALK positive non-small cell lung cancer (ALK+ NSCLC).
- Truncation in CCND1 mRNA 3′ UTR Is Associated with An Aggressive Phenotype and Chemoresistance
- Data from Identifying and Targeting ROS1 Gene Fusions in Non–Small Cell Lung Cancer
- Data from Identifying and Targeting ROS1 Gene Fusions in Non–Small Cell Lung Cancer
- Supplementary Figure 3 from Identifying and Targeting ROS1 Gene Fusions in Non–Small Cell Lung Cancer
- Supplementary Table 1 from Identifying and Targeting ROS1 Gene Fusions in Non–Small Cell Lung Cancer